Lifetech Scientific Stock Analysis
| LFTSF Stock | USD 0.23 0.00 0.00% |
LifeTech Scientific holds a debt-to-equity ratio of 0.003. LifeTech Scientific's financial risk is the risk to LifeTech Scientific stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
LifeTech Scientific's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. LifeTech Scientific's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps LifeTech Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect LifeTech Scientific's stakeholders.
For many companies, including LifeTech Scientific, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for LifeTech Scientific, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, LifeTech Scientific's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that LifeTech Scientific's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which LifeTech Scientific is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of LifeTech Scientific to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, LifeTech Scientific is said to be less leveraged. If creditors hold a majority of LifeTech Scientific's assets, the Company is said to be highly leveraged.
LifeTech Scientific is overvalued with Real Value of 0.19 and Hype Value of 0.23. The main objective of LifeTech Scientific pink sheet analysis is to determine its intrinsic value, which is an estimate of what LifeTech Scientific is worth, separate from its market price. There are two main types of LifeTech Scientific's stock analysis: fundamental analysis and technical analysis.
The LifeTech Scientific pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and LifeTech Scientific's ongoing operational relationships across important fundamental and technical indicators.
LifeTech |
LifeTech Pink Sheet Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of LifeTech Scientific was now reported as 0.56. The company had not issued any dividends in recent years. LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the Peoples Republic of China. Lifetech Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1144 people.The quote for LifeTech Scientific is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about LifeTech Scientific contact Yuehui Xie at 86 75 5860 26250 or learn more at https://www.lifetechmed.com.LifeTech Scientific Investment Alerts
| LifeTech Scientific generated a negative expected return over the last 90 days | |
| LifeTech Scientific has some characteristics of a very speculative penny stock | |
| About 17.0% of the company outstanding shares are owned by corporate insiders |
LifeTech Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LifeTech Scientific's market, we take the total number of its shares issued and multiply it by LifeTech Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.LifeTech Profitablity
The company has Profit Margin (PM) of 0.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.37 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.37.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LifeTech Scientific, as well as the relationship between them.LifeTech Scientific Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in LifeTech Scientific price series with the more recent values given greater weights.
LifeTech Scientific Debt to Cash Allocation
Many companies such as LifeTech Scientific, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
LifeTech Scientific has accumulated 10.19 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. LifeTech Scientific has a current ratio of 3.73, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist LifeTech Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, LifeTech Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LifeTech Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LifeTech to invest in growth at high rates of return. When we think about LifeTech Scientific's use of debt, we should always consider it together with cash and equity.LifeTech Scientific Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the LifeTech Scientific's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of LifeTech Scientific, which in turn will lower the firm's financial flexibility.About LifeTech Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how LifeTech Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LifeTech shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as LifeTech Scientific. By using and applying LifeTech Pink Sheet analysis, traders can create a robust methodology for identifying LifeTech entry and exit points for their positions.
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the Peoples Republic of China. Lifetech Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1144 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding LifeTech Scientific to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for LifeTech Pink Sheet analysis
When running LifeTech Scientific's price analysis, check to measure LifeTech Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeTech Scientific is operating at the current time. Most of LifeTech Scientific's value examination focuses on studying past and present price action to predict the probability of LifeTech Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeTech Scientific's price. Additionally, you may evaluate how the addition of LifeTech Scientific to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |